Verfora
Verfora AG is a Swiss consumer healthcare company marketing 70+ brands and 400+ OTC pharmaceuticals, supplements, and dermo-cosmetics through more than 2,500 Swiss pharmacies and drugstores, as a wholly-owned subsidiary of Galenica AG.
- Company typePrivate
- Founded1953
- HeadquartersVillars-sur-glâne, Switzerland
- Headcount101–250
- GTM typeB2C
- OfferingHardware or Manufacturing
What Verfora does
Verfora AG is a Swiss consumer healthcare company that formulates, markets, and distributes over-the-counter (OTC) pharmaceuticals, health supplements, dermo-cosmetics, and wellness products across 12 health categories including allergies, cold and flu, pain relief, wound healing, complementary medicine, and vitamins. The company distributes more than 70 quality brands and 400+ products — including established names such as Algifor, Merfen, Triofan, Bucco Tantum, Kamillosan, Perskindol, Veractiv, and ThermaCare — through an exclusive Swiss retail network of more than 2,500 pharmacies and drugstores, supplemented by online pharmacy partners such as Amavita, Coopvitality, and Zurrose. Verfora also operates the Verfora Campus B2B portal for healthcare professional training and supports consumer engagement through health guides, the Verfora Gesundheitsratgeber podcast, and the Quälgeister gamification app. Its September 2021 acquisition of Spagyros AG and 2022 partnership with Boiron SA Schweiz have expanded the company's footprint in complementary and homeopathic medicine.
Verfora's underlying operations center on brand marketing, regulatory compliance (including a dedicated pharmacovigilance office in Bern), and channel sales rather than proprietary technology development. The company's only disclosed AI capability is a text-based product search assistant ("KI-Assistenten") on its website that recommends products based on user health queries. There is no evidence of a proprietary technology platform, R&D-driven discovery pipeline, or data flywheel. The product portfolio combines decades-old heritage brands with more recent additions acquired via M&A and partnerships.
The company generates revenue through one-time OTC product sales at price points set by retail partners; specific pricing is not publicly disclosed. Its go-to-market is product-led but channel-mediated: products reach consumers exclusively through the Swiss pharmacy and drugstore network, where trained pharmacists provide recommendations. Verfora AG is a wholly-owned subsidiary of Galenica AG, Switzerland's largest healthcare group, and is led by CEO Stefan Wälti from its headquarters in Villars-sur-Glâne. The company's geographic focus is entirely domestic — Switzerland within the DACH region — with no disclosed international expansion plans.
Verfora firmographics
Firmographics- Name
- Verfora
- Legal name
- VERFORA AG
- Website
- https://verfora.ch
- Company type
- Private
- Founded year
- 1953
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Verfora AG is a Swiss consumer healthcare company marketing 70+ brands and 400+ OTC pharmaceuticals, supplements, and dermo-cosmetics through more than 2,500 Swiss pharmacies and drugstores, as a wholly-owned subsidiary of Galenica AG.
- Ownership category
- akta.pro rank
Verfora industry classification
Industry- Product category
- Consumer Healthcare (OTC Pharmaceuticals)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)
- akta.pro secondary industries
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where Verfora is headquartered
LocationHeadquarters
- HQ city
- Villars-sur-glâne
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Verfora business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Consumer Healthcare Products: Verfora generates revenue through the sale of OTC pharmaceuticals, health supplements, dermo-cosmetics, and wellness products distributed through pharmacies, drugstores, and online channels in Switzerland.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Verfora product offering
Product offeringCore offering
Verfora AG is a Swiss pharmaceutical and consumer healthcare company that formulates, markets, and distributes over 70 brands and 400+ OTC products across categories including pain relief, cold and flu, wound disinfection, dermo-cosmetics, vitamins and supplements, complementary medicine, baby care, and digestive health. Products are sold without prescription through a network of more than 2,500 pharmacies and drugstores in Switzerland, supplemented by online pharmacy partners.
Product overview
VERFORA is a Swiss pharmaceutical and consumer healthcare company offering a broad portfolio of over 70 quality brands and 400+ products distributed through 2,500+ pharmacies and drugstores in Switzerland. The product range centers on Consumer Healthcare (OTC) products across 12 health categories: allergies & hay fever, eye & ear care, dermocosmetics, disinfection & wound healing, cold & flu, skin/hair/nails, complementary & herbal medicine, mosquito & tick protection, pain relief, pregnancy/baby/children, digestion/travel/weight management, and vitamins/supplements. Key brands include Algifor (pain relief with ibuprofen), Merfen (wound disinfection), Triofan (cold remedies), Bucco Tantum (throat treatments), Veractiv (vitamins/supplements), Kamillosan (chamomile-based skincare), and Perskindol (topical analgesics). VERFORA operates B2B portals (Campus) for healthcare professional training and maintains consumer engagement through the Quälgeister gamification app and the VERFORA Gesundheitsratgeber health podcast. The company also offers an AI-powered product search assistant on its website.
Differentiator
Problem solved
Functional benefit
Brands
- Veractiv: Product line including vitamins, minerals, and supplements for energy and immune support
- Algifor
- Triofan
- Merfen
- Derma-Merfen
- Kamillosan
- Perskindol
- Triomer
- Vicks
- Bucco Tantum
- Solarcaïne
- Dermatix
- ThermaCare
- Vita-Merfen
- Osanit
- META-CARE
- OMNi-BiOTiC
Products and services
- Algifor Dolo Forte OTC pain relief medication containing ibuprofen (suspension and sachets); analgesic, anti-inflammatory, and fever-reducing agent for headaches, pain, and inflammation, sold in pharmacies and drugstores.
- Merfen Classic Wound disinfectant containing chlorhexidine digluconate and benzoxonium chloride; provides pain-free disinfection of minor wounds, burns, and insect bites without burning.
- Bucco Tantum Throat spray and solution containing benzydamine; provides anti-inflammatory, pain-relieving, and antibacterial action for sore throats, tonsillitis, mouth inflammation, and aphtha.
- Triofan Schnupfen Nasal spray and drops containing xylometazoline and carbocisteine; reduces nasal swelling and liquefies mucus for relief from colds.
- Vita-Merfen MediGel Hydroactive lipogel for moist wound healing; cools, relieves pain, and reduces scarring and infection risk, suitable for minor burns, cuts, scrapes, and tattoos.
- Merfen Octenidin Wound disinfectant spray and gel containing octenidine dihydrochloride; provides antiseptic wound treatment effective against bacteria, fungi, and viruses within 60 seconds.
- Solarcaine Lotion Sunburn relief lotion containing lidocaine; cools, soothes, and moisturizes skin while relieving pain and itching from sunburn and insect bites.
- Kamillosan Liquidum Chamomile-based liquid (Manzana chamomile) for inflammation of skin and mucous membranes; for mouth/throat inflammation, rhinitis, eczema, and hemorrhoids.
- Kamillosan Creme Chamomile cream for minor skin injuries; anti-inflammatory, wound-healing, and mildly disinfecting for scratches, scrapes, cracked skin, and blisters.
- Dermatix Ultra Gel Silicone gel for scar prevention and treatment; reduces raised scars and relieves pain, itching, and redness. Contains silicone and Vitamin C ester.
- Veractiv Energy Energy supplement powder with amino acids (arginine, aspartate) and magnesium; improves physical and mental performance during exertion, stress, and fatigue.
- Veractiv Multi-Vitamin Kids Gummies Gummy vitamins for children with 7 vitamins, iodine, choline, and DHA from microalgae; supports vitality and immune system in children from age 4.
- Dynamisan Forte Strengthening tonic containing amino acids (arginine aspartate); boosts physical and mental performance during exhaustion and recovery periods.
- Tonoglutal Vitality supplement containing glutamic acid, vitamins B1, C, magnesium, and phosphate; supports mental and physical performance during weakness, mental fatigue, and concentration issues.
- Osa Zahngel Plant-based teething gel with propolis for soothing infant teething pain.
- Osanit Zahnen Globuli Homeopathic medicine for baby teething relief.
- Perskindol Classic Gel Topical pain relief gel for muscle and joint pain; analgesic for small to medium body areas.
- ThermaCare Wärmeumschläge Heat wraps for back pain, neck/shoulder pain, and larger body areas; provides targeted heat therapy for muscle and joint pain.
- Algifor Dolo Duo Dual-action pain reliever combining paracetamol and ibuprofen for stronger pain relief.
- META-CARE Darm Fit Nutritional supplement with vitamins, minerals, and trace elements supporting intestinal health; contains L-glutamine, magnesium citrate, zinc, and antioxidants.
Companies that use Verfora
Customer profileSegments3 records
Ideal customer profiles3 records
Verfora technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Verfora partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor and core.
- Boiron SA SchweizminorVerfora and Boiron SA Schweiz entered into a partnership to expand their consumer healthcare product offerings in the Swiss market.
- Spagyros AGcoreVerfora acquired 100% of Spagyros AG in September 2021. Spagyros is a successful Swiss company specializing in the manufacture and marketing of complementary medicine products. This acquisition expanded Verfora's offering in phyto- and complementary medicine and strengthened their leading position in the Swiss Consumer Healthcare market (CHC). The companies had maintained a strategic partnership since 2018.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Verfora competitors and assessment
Company assessmentDirect peers
- Johnson & Johnson Consumer Health: J&J's consumer health portfolio (Neutrogena, Zyrtec, Reactine) is sold through Swiss pharmacies and competes with Verfora's dermocosmetics and allergy categories via the same channel structure.
- Haleon (formerly GSK Consumer Healthcare): Haleon markets global OTC power brands (Voltaren, Panadol, Centrum, Sensodyne) in Switzerland and competes head-to-head with Verfora's Algifor in analgesics and Triofan in cold/flu. Highly comparable as a branded OTC marketer relying on pharmacy distribution.
- Procter & Gamble Health (Switzerland): P&G distributes consumer health brands (Vicks, which Verfora also licenses) in Switzerland and competes in cold/flu and OTC categories through similar pharmacy and drugstore channels. Verfora's license of Vicks creates a both-partner-and-competitor dynamic.
- Boiron SA: Boiron is the global homeopathic medicine leader and entered a 2022 partnership with Verfora in Switzerland while still competing in complementary and homeopathic OTC categories. Highly comparable in the natural/homeopathic OTC segment.
- Sanofi Consumer Healthcare: Sanofi's Consumer Healthcare business (formerly Opella) sells OTC brands including Dulcolax, Essentiale, and Mucosolvan through Swiss pharmacies, overlapping directly with Verfora's digestive, cold/flu, and wellness categories.
- Bayer Consumer Health (Switzerland): Bayer's Consumer Health division markets OTC brands (Aspirin, Bepanthen, Canesten) in Switzerland through pharmacy channels, directly competing with Verfora's analgesic, skin care, and wound care portfolio. Both companies sell branded OTC through Swiss pharmacies and drugstores with similar go-to-market.
- Weleda AG: Weleda is a Swiss-headquartered natural cosmetics and anthroposophic medicine company selling through pharmacies and drugstores, directly competing with Verfora's Kamillosan and complementary medicine portfolio. Strong geographic and channel overlap.
Others
- Galexis AG: Galexis is Galenica AG's pharmaceutical wholesale and logistics arm — sister company to Verfora within the parent group. Not a direct competitor but a key distribution partner and ecosystem participant that could internalize or externalize Verfora's logistics.
Regional players
- OM Pharma SA: OM Pharma is a Geneva-based specialty pharmaceutical company focused on respiratory and immunology products sold through Swiss pharmacies. Operates in adjacent OTC and consumer health categories with similar Swiss market focus.
- Schwabe Pharma AG: Schwabe is a German leader in phytomedicine whose products are distributed in Switzerland through pharmacies. Comparable as a branded herbal/plant-based OTC player with similar product positioning to Verfora's complementary medicine range.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Verfora social profiles
Digital presenceVerfora financial estimates
Financial estimateRevenue estimate
Valuation estimate
Verfora leadership team
Management profileNumber of profiles
Profiles3 records
Verfora subsidiaries and ownership
Company hierarchySubsidiaries1 record
Verfora funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Verfora M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Verfora
What does Verfora do?
Verfora AG is a Swiss pharmaceutical and consumer healthcare company that formulates, markets, and distributes over 70 brands and 400+ OTC products across categories including pain relief, cold and flu, wound disinfection, dermo-cosmetics, vitamins and supplements, complementary medicine, baby care, and digestive health. Products are sold without prescription through a network of more than 2,500 pharmacies and drugstores in Switzerland, supplemented by online pharmacy partners.
Is Verfora a public or private company?
Verfora is a private company. It is classified as corporate owned and is currently operating.
When was Verfora founded?
Verfora was founded in 1953. It employs 101 to 250 people.
Where is Verfora based?
Verfora is headquartered in Villars-sur-glâne, Switzerland, in the Europe region.
How does Verfora make money?
One revenue line is on record: consumer Healthcare Products.
Who are Verfora's main competitors?
Direct peers on record are Johnson & Johnson Consumer Health, Haleon (formerly GSK Consumer Healthcare), Procter & Gamble Health (Switzerland), Boiron SA, Sanofi Consumer Healthcare, Bayer Consumer Health (Switzerland) and Weleda AG. Galexis AG is listed as an others. Regional players are OM Pharma SA and Schwabe Pharma AG.
Does Verfora have an API?
No public API is recorded for Verfora.
What industry is Verfora in?
Verfora's product category is Consumer Healthcare (OTC Pharmaceuticals). Its primary akta.pro industry code is CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief), with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 325412 and its SIC code is 2834.